These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 22575535

  • 1. Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring.
    Mohammed Iqbal AK, Khan AY, Kalashetti MB, Belavagi NS, Gong YD, Khazi IA.
    Eur J Med Chem; 2012 Jul; 53():308-15. PubMed ID: 22575535
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
    Khazi MI, Belavagi NS, Kim KR, Gong YD, Khazi IA.
    Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650
    [Abstract] [Full Text] [Related]

  • 3. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
    Sohda T, Mizuno K, Momose Y, Ikeda H, Fujita T, Meguro K.
    J Med Chem; 1992 Jul 10; 35(14):2617-26. PubMed ID: 1635060
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy)-2-methyl propanoic acid derivatives.
    Mokale SN, Elgire RD, Sakle N, Shinde DB.
    Bioorg Med Chem Lett; 2011 Jan 15; 21(2):682-5. PubMed ID: 21193309
    [Abstract] [Full Text] [Related]

  • 5. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
    Lee HW, Kim BY, Ahn JB, Kang SK, Lee JH, Shin JS, Ahn SK, Lee SJ, Yoon SS.
    Eur J Med Chem; 2005 Sep 15; 40(9):862-74. PubMed ID: 15908051
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{[4-(1-naphthyl)-1,3-thiazol-2-yl] amino}-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives.
    Imran M, Yar MS, Khan SA.
    Acta Pol Pharm; 2009 Sep 15; 66(1):51-6. PubMed ID: 19226969
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
    Nazreen S, Alam MS, Hamid H, Yar MS, Shafi S, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Ali Y, Kharbanda C, Pillai KK.
    Eur J Med Chem; 2014 Nov 24; 87():175-85. PubMed ID: 25255433
    [Abstract] [Full Text] [Related]

  • 8. Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives.
    Mokale SN, Elgire RD, Sakle NS, Shinde DB.
    Arch Pharm (Weinheim); 2012 Jan 24; 345(1):22-7. PubMed ID: 22076967
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and Evaluation of the Hypoglycemic and Hypolipidemic Activity of Sulfonamide-benzothiazole Derivatives of Benzylidene-2,4- thiazolidnedione.
    Ahmadi A, Khalili M, Sohrabi L, Delzendeh N, Nahri-Niknafs B, Ansari F.
    Mini Rev Med Chem; 2017 Jan 24; 17(8):721-726. PubMed ID: 27903228
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antidiabetic activity of novel 2,4-thiazolidinedione derivatives containing a thiazole ring.
    Bozdağ-Dündar O, Ceylan-Unlüsoy M, Verspohl EJ, Ertan R.
    Arzneimittelforschung; 2006 Jan 24; 56(9):621-5. PubMed ID: 17063636
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and glucose uptake activity of some novel glitazones.
    Kar K, Krithika U, Mithuna, Basu P, Santhosh Kumar S, Reji A, Prashantha Kumar BR.
    Bioorg Chem; 2014 Oct 24; 56():27-33. PubMed ID: 24927033
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR, Yejella RP, Akula A, Guntuku GS, Doddi BR, Vutla VR, Anagani SR, Adimulam LS, Vyricharla AK.
    Bioorg Med Chem Lett; 2012 Oct 15; 22(20):6442-50. PubMed ID: 22981328
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives.
    Naim MJ, Alam MJ, Nawaz F, Naidu VGM, Aaghaz S, Sahu M, Siddiqui N, Alam O.
    Bioorg Chem; 2017 Aug 15; 73():24-36. PubMed ID: 28582649
    [Abstract] [Full Text] [Related]

  • 14. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
    Reddy KA, Lohray BB, Bhushan V, Reddy AS, Kishore PH, Rao VV, Saibaba V, Bajji AC, Rajesh BM, Reddy KV, Chakrabarti R, Rajagopalan R.
    Bioorg Med Chem Lett; 1998 May 05; 8(9):999-1002. PubMed ID: 9871696
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
    da Costa Leite LF, Veras Mourão RH, de Lima Mdo C, Galdino SL, Hernandes MZ, de Assis Rocha Neves F, Vidal S, Barbe J, da Rocha Pitta I.
    Eur J Med Chem; 2007 Oct 05; 42(10):1263-71. PubMed ID: 17448573
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.
    Kumar A, Sharma S, Gupta LP, Ahmad P, Srivastava SP, Rahuja N, Tamrakar AK, Srivastava AK.
    Bioorg Med Chem; 2012 Mar 15; 20(6):2172-9. PubMed ID: 22341243
    [Abstract] [Full Text] [Related]

  • 17. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
    Madhavan GR, Chakrabarti R, Kumar SK, Misra P, Mamidi RN, Balraju V, Kasiram K, Babu RK, Suresh J, Lohray BB, Lohrayb VB, Iqbal J, Rajagopalan R.
    Eur J Med Chem; 2001 Mar 15; 36(7-8):627-37. PubMed ID: 11600232
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
    Shukla S, Kumar P, Das N, Moorthy NS, Shrivastava SK, Trivedi P, Srivastava RS.
    Med Chem; 2012 Sep 15; 8(5):834-45. PubMed ID: 22741802
    [Abstract] [Full Text] [Related]

  • 19. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone).
    Sohda T, Ikeda H, Meguro K.
    Chem Pharm Bull (Tokyo); 1995 Dec 15; 43(12):2168-72. PubMed ID: 8582019
    [Abstract] [Full Text] [Related]

  • 20. Antihyperglycemic and antihyperlipidemic effects of newly synthesized glibenclamide analogues on streptozotocin-diabetic rats.
    Ahmadi A, Khalili M, Farsadrooh M, Ghiasi M, Nahri-Niknafs B.
    Drug Res (Stuttg); 2013 Dec 15; 63(12):614-9. PubMed ID: 23828271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.